• Profile
Close

Efficacy of alteplase 1 vs 2 mg dose in restoring haemodialysis catheter function (Alte-dose 2): A randomized double-blind controlled study

Nephrology Feb 02, 2020

El-Masri MM, et al. - By performing this double-blind, randomized, controlled clinical trial, researchers compared alteplase 2 mg vs 1 mg in terms of effectiveness in restoring haemodialysis catheter occlusion (HDC) function. This inquiry was carried out at a single-centre in southwestern Ontario, Canada. They used Kaplan–Meier, Cox-proportional hazard and clustered logic regression analyses to determine the rate of clot resolution, catheter replacements, catheter stripping, and mean catheter survival time. This analysis included 48 haemodialysis patients who afforded 252 catheter occlusion events. In the 2 mg group vs in the 1 mg group, the rate of clot resolution at the catheter site was estimated to be 85.7% vs 84.9%, respectively. Just six catheter removals and 10 catheter stripping events were reported. Findings revealed the equivalent effectiveness of alteplase 1 mg vs alteplase 2 mg in restoring HDC malfunction. In addition, alteplase 1 mg may lead to a cost reduction in haemodialysis units.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay